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Objective: In 2009, Australia implemented mandatory folic acid fortiﬁcation in wheat ﬂour for bread-
making. The primary aim was to improve folate status in reproductive-aged women to reduce neural
tube defect incidence. However, folic acid consumption has consequently increased in all demographics.
Blood folate is inversely associated with homocysteine levels, a risk factor for multiple diseases.
Therefore, we assessed the impact of mandatory folic acid fortiﬁcation on homocysteine levels in elderly
Australians.
Methods: Homocysteine and blood folate levels were compared between two elderly cross-sectional
cohorts (pre-versus post-mandatory folic acid fortiﬁcation). Importantly, dietary habits were assessed
to evaluate the confounding inﬂuence of altered dietary patterns not related to fortiﬁcation.
Results: Post-fortiﬁcation, plasma homocysteine levels (10.6 vs. 14.5 mmol/L) and hyperhomocysteinemia
incidence (27.2% vs 56.3%) were signiﬁcantly reduced, relative to the pre-fortiﬁcation subjects. This was
associated with increased blood folate (red cell: 1243 vs 1066 nmol/L, serum 28.0 vs 23.9 nmol/L), and
increased intake of synthetic folic acid (366.8 vs 231.0 DFE/day) but not natural folate (332.7 vs 323.6
DFE/day). Limited other differences were detected in dietary intake patterns between groups. The pos-
itive relationship between homocysteine levels and age was abrogated post-fortiﬁcation (p ¼ 0.3 vs p ¼
0.0003).
Conclusions: A potential off-target beneﬁt of mandatory folic acid fortiﬁcation in Australia was
demonstrated. With many countries still considering the merits and consequences of mandatory forti-
ﬁcation policies, it is important to unravel the off-target effects including dietary context.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Mandatory fortiﬁcation of wheat ﬂour used for bread-making
with folic acid commenced in Australia in September 2009. The
Australian New Zealand Food Standards require fortiﬁcation at
2e3 mg of folic acid per kilogram of wheat ﬂour, resulting in
approximately 0.13 mg of folic acid per 100 g of bread [1]. Prior to
mandatory fortiﬁcation, some foods, primarily breakfast cereals,Public Health, University of
58, Australia.
(E.L. Beckett).
Inc. This is an open access article uwere voluntarily fortiﬁed by manufacturers. The primary aim of
mandatory fortiﬁcation was to improve the folate status of women
of reproductive-age to reduce the incidence of neural tube defects
[2]. However, consumption of fortiﬁed products is not limited to
this target group and consequently, fortiﬁcation has led to
increased exposure to folic acid in other demographics, including
the elderly. While off-target exposures has been the source of some
controversy [3], there may also be beneﬁts.
Low folate levels are also associated with elevated levels of
blood homocysteine (Hcy) [4]. Ultimately, Hcy levels are a function
of the equilibrium between the methylation and transsulfuration
pathways and dietary intake of folate, vitamin B12, and to a lessernder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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deﬁciency of intake of one or more of these vitamins. Lifestyle
exposures such as excessive alcohol consumption, cigarette smok-
ing, and physical inactivity may also play a role in modulating Hcy
levels [6]. Hcy levels also increase with aging [7] and are higher in
males [8].
Hyperhomocysteinemia increases risk of cardiovascular dis-
eases, including atherosclerosis, myocardial infarction and stroke
[9e13] and neurodegenerative diseases such as dementia [14,15],
Alzheimer's disease [16,17], Parkinson's disease [18,19] and cogni-
tive decline [20]. Mechanisms may be direct or indirect and include
promotion of low-density lipoprotein oxidation [21,22] and
inﬂammation [23], competition with inhibitory neurotransmitters
[24], and damage to endothelial and neuronal cells [20,22,25e28].
While folic acid and vitamin B12 supplementation can reduce
Hcy, a consensus has yet to be reached as to whether this reduces
risk or improves symptoms of either cardiovascular or neurode-
generative diseases, as results have been inconsistent
[13,14,29e41]. These inconsistencies may be largely attributed to
limitations of study design. Considerable differences exist in the
dose and duration of supplementation across trials [13,14,29e41].
Other studies are based on reported supplement use, rather than a
standardised intervention. For multi-factorial diseases the beneﬁts
of lowering Hcy may be too small for trials to detect. Additionally,
supplementation trials conducted in countries with mandatory or
voluntary fortiﬁcation might lead to a masking of the experimental
effects, due to higher baseline levels [42].
Moreover, as neurodegenerative and cardiovascular diseases
commonly present in later life [43e45], trials of supplementation in
elderly cohorts [13,14,31,36e39], particularly following the onset of
hyperhomocysteinemia or symptomatic disease, may not be sufﬁ-
cient to reverse the damage already sustained by sub-clinical de-
ﬁciencies in the preceding decades. Therefore, reducing Hcy levels
via systematic fortiﬁcation over the long term may be more prac-
tical for reducing risk of primary disease than later life supple-
mentation. Indeed, this may be an off-target beneﬁt of mandatory
folic acid fortiﬁcation in Australia. However, the inﬂuence of Aus-
tralia's mandatory folic acid fortiﬁcation policy on homocysteine
levels, particularly in the at risk elderly demographic, remains to be
investigated. It is also important to remember that any dietary
intervention must be considered in the context of other back-
ground dietary exposures.
In this study, the blood levels of folate (serum and red cell) and
Hcy were assessed in two elderly cross-sectional cohorts from the
Central Coast of NSW, Australia. The samples from one cross-
sectional cohort were collected shortly prior to the introduction
of mandatory folic acid fortiﬁcation in Australia, and the other was
collected shortly after implementation. The dietary habits of par-
ticipants were also assessed to evaluate the potential confounding
inﬂuence of altered dietary intake of folate, from sources not
related to mandatory fortiﬁcation.
2. Methods
2.1. Subjects and sample collection
The pre-fortiﬁcation subjects was obtained from a larger study
of patients undergoing routine colonoscopy at Gosford Hospital
(Central Coast, NSW, Australia) [46]. Two-hundred and seven par-
ticipants who gave blood and completed food frequency ques-
tionnaires were recruited prior to the introduction of mandatory
folic acid fortiﬁcation in Australia in September 2009. The post-
fortiﬁcation subjects (sample collection commencing mid-2010)
was obtained from a cross-sectional cohort of elderly individuals
(65 years) living on the Central Coast of NSW (The RetirementHealth and Lifestyle Study [47]). A total of 649 participants in this
group gave blood and completed food frequency questionnaires.
Only participants 65 years of age were included in this anal-
ysis. Participants were excluded if blood biochemistry measures
were missing or food frequency questionnaire were deemed
invalid. Criteria for deeming a questionnaire invalid were missed
pages, extreme excess (>30,000 kj/day) or deﬁcient (<3500 kj/day)
energy consumption [48], or reported excessive consumption of a
single food group (11 serves/day). After exclusions, 115 partici-
pants (50% female; mean age 72.7 year, standard error ± 0.5 years)
were included in the pre-fortiﬁcation cohort and 475 participants
(54% female: mean age 77.2 years, standard error ± 0.3 years) were
included in the post-fortiﬁcation cohort.
Fasting blood samples were collected in EDTA lined tubes and
stored at 20 C as whole blood, or collected in Lithium Heparin
tubes (plasma) or with a tubes containing clot activator (serum).
Samples for serum and plasmawere centrifuged (1500 g, 10 min) to
obtained serum or plasma (serum left for 30 min for clotting), and
stored at 80 C. Written informed consent was obtained from all
participants. Approval was obtained from the University of New-
castle Human Research Ethics Committee (approval numbers H-
429-0407 and H-2008-0431 for the pre- and post-fortiﬁcation co-
horts, respectively).
2.2. Blood biochemistry
Serum and red cell folate, and serum vitamin B12 levels were
assessed by the Institute for Clinical Pathology and Medical
Research (pre-fortiﬁcation subjects) and the Hunter Area Pathology
Service (post-fortiﬁcation subjects) using standardised chemilu-
minescent assays. Total plasma Hcy was measured by selective
ﬂuorescence assay (JD Biotech Corp, Taipei, Taiwan) [46].
2.3. Food frequency questionnaires
The pre-fortiﬁcation food frequency questionnaires were ana-
lysed using Foodworks™ 2.10.146 (Xyris Software, Brisbane, QLD,
Australia), which includes the AusFoods (brands), Aus Nut (base
foods) and the New Zealand Vitamin and Mineral Supplements
1999 databases. Data for foods commonly voluntary fortiﬁed with
folic acid were entered in a brand speciﬁc manner [49]. The post-
fortiﬁcation food frequency questionnaires were analysed using
Foodworks Professional 7 (Xyris Software, Brisbane, QLD,
Australia), which reﬂects folic acid values post fortiﬁcation using
2010 databases. Food frequency questionnaires were as published
in previous studies [46,50] and were adapted from the CSIRO
version [51]. Lists of supplements and frequency of intake were
provided by participants. Serves per day were calculated for the
major food groups based on the standard serving sizes in the
Australian dietary guidelines [52]. Food groups were further strat-
iﬁed where the strata may signiﬁcantly contribute to folate intake
(for example bread and cereal as strata to the food group grains).
Alcohol intake was included in the food frequency questionnaires.
Smoking habits were also collected in a lifestyle survey (grouped as
current, never or ex-smokers).
2.4. Statistics
Nominal logistic and linear regression were used for multivari-
able models. Least-squares means and 95% conﬁdence intervals are
reported throughout, with adjustment for age and sex age excluded
where it is a variable of interest. Least-squares means were
compared using t-tests (or non-parametric equivalents) or c2 tests,
with effect likelihood ratio tests. Outcomes were considered to be
statistically signiﬁcant at p  0.05. Where homocysteine was the
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ing history, reported alcohol consumption and serum vitamin B12
levels.
3. Results
3.1. Comparison of pre- and post-fortiﬁcation folate and Hcy levels
In the pre-fortiﬁcation subjects, only one participant had red cell
folate levels indicative of deﬁciency (<340 nmol/L [53]). No par-
ticipants were deﬁcient in the post-fortiﬁcation cohort. In the pre-
fortiﬁcation subjects, the mean red cell folate level was 1066 nmol/
L (95% CI: 977e1156). As anticipated, the mean red cell folate level
was signiﬁcantly higher in the post fortiﬁcation subjects, at
1243 nmol/L (95% CI: 1203e1283; p ¼ 0.0005; Fig. 1A). These re-
sults were not signiﬁcantly altered when adjustments were applied
for smoking history and reported alcohol intake.
The percentage of participants with serum folate levels indica-
tive of deﬁciency (<10 nmol/L [53]) was signiﬁcantly reduced post-
fortiﬁcation, from 6.3% in the pre-fortiﬁcation subjects, to 2.9%
post-fortiﬁcation (c2¼ 9.4, p¼ 0.002). The mean serum folate level
in the pre-fortiﬁcation subjects was 23.9 nmol/L (95% CI:
21.1e26.6), which increased to 28.0 nmol/L (95% CI: 26.8e29.3;
p ¼ 0.008) post-fortiﬁcation (Fig. 1B). These results were not
signiﬁcantly altered when adjustments were applied for smoking
history and reported alcohol intake.
Mean plasma Hcy levels were 14.5 mmol/L (95% CI: 13.3e15.7)
pre-fortiﬁcation, which was signiﬁcantly higher than the post-
fortiﬁcation mean of 10.6 mmol/L (95% CI: 10.0e11.1; p < 0.0001;
Fig. 1C). Pre-fortiﬁcation, 56.3% of participants had elevated plasma
Hcy (>13 mmol/L [54]) which was signiﬁcantly lowered to 27.2%
post-fortiﬁcation (c2 ¼ 25.7, p < 0.0001). This result remained
signiﬁcant when additional adjustment was applied for serum
vitamin B12 levels (c2 ¼ 41.1, p < 0.0001), and with additional ad-
justments for smoking history and reported alcohol intake.
3.2. Comparison of reported intakes of natural and synthetic folate
containing foods & supplements
Analysis of food frequency questionnaires and reported sup-
plement intake revealed that there was no signiﬁcant difference in
the intake of natural folate (naturally found in foods) between the
pre- and post-fortiﬁcation cross-sectional cohorts. Average esti-
mated intake of natural folate was 323.6 DFE/day (95% CI:
299.8e347.5) in the pre-fortiﬁcation subjects, and 332.7 DFE/day
(95% CI: 319.5e340.2) in the post-fortiﬁcation subjects (p ¼ 0.6;Fig. 1. Comparison of A) red cell folate, B) serum folate and C) plasma homocysteine levels
folic acid fortiﬁcation of bread-making wheat ﬂour in Australia. Least-squares means and c
further adjusted for smoking history, alcohol intake and vitamin B12 levels. n ¼ 115 (pre-foFig. 2A). However, the estimated total intake of synthetic folate
(folic acid) was signiﬁcantly increased from 231.0 DFE/day (95% CI:
137.0e324.7) pre-fortiﬁcation to 366.8 DFE/day (95% CI:
328.1e412.5) in the post-fortiﬁcation subjects (p ¼ 0.01; Fig. 2B).
Pre-fortiﬁcation, 22.5% of participants reported consuming a
supplement containing folic acid. A signiﬁcantly lower percentage
(13.5%) of the post-fortiﬁcation subjects reported taking supple-
ments (c2¼ 6.3, p¼ 0.01). However, the average intake of folic acid
from supplements was not signiﬁcantly different with a mean
intake of 62.0 mg/day (95% CI: 17.2e107.0) pre-fortiﬁcation, and
52 mg/day (95% CI: 28.5-75-4) post-fortiﬁcation.
3.3. Interactions with sex and age
Sex was an independent predictor of plasma Hcy (p ¼ 0.008),
with males having higher levels. However, there was no interaction
between sex and cohort in predicting Hcy level (p-
interaction ¼ 0.3), indicating that the relationship between cohort
(fortiﬁcation) and Hcy levels was not biased by sex. Red cell and
serum folate levels did not vary by sex (p ¼ 0.3 and 0.2,
respectively).
There was a signiﬁcant interaction between age and cohort in
predicting Hcy level (p-interaction ¼ 0.05), with a greater effect of
fortiﬁcation seen with increasing age. Interestingly, the correlation
between age and Hcy was limited to the pre-fortiﬁcation cohort
(b ¼ 0.12 r2 ¼ 0.330, p ¼ 0.0003; Fig. 3A), with no signiﬁcant cor-
relation in the post-fortiﬁcation cohort (b ¼ 0.04, r2 ¼ 0.010,
p ¼ 0.3; Fig. 3B). Additional adjustment for sex, smoking history,
alcohol intake and vitamin B12 levels did not signiﬁcantly alter
these results. No signiﬁcant relationships between age and red cell
or serum folate levels were observed.
4. Discussion
While it is well established that folate status and Hcy levels are
inversely related, the speciﬁc impact of mandatory folic acid forti-
ﬁcation on circulating Hcy has not beenwell established. This study
demonstrates a reduction in Hcy levels in post-fortiﬁcation sub-
jects' relative to a pre-fortiﬁcation cohort recruited from the same
geographical region of Australia. Importantly, the results presented
here demonstrate an increase intake of synthetic folic acid but not
natural folate following fortiﬁcation, despite a reduction in the
reported consumption of brassica vegetables. Assessment of back-
ground diet as a potential confounder is often ignored in studies
comparing pre- and post-fortiﬁcation cohorts. Including this anal-
ysis is important if changes in Hcy levels are to be attributed toin two cohorts, prior to (pre-fortiﬁcation) and following (post-fortiﬁcation) mandatory
onﬁdence intervals (adjusted for age and sex) are presented. Homocysteine results are
rtiﬁcation) and 475 (post-fortiﬁcation).
Fig. 2. Comparison of estimated intake of A) natural folate and B) synthetic folate, prior to (pre-fortiﬁcation) and following (post-fortiﬁcation) mandatory folic acid fortiﬁcation of
bread-making wheat ﬂour in Australia. Results are reported as dietary folate equivalents (DFE) due to the differences in bioavailability between natural and synthetic folates. Least-
squares means and conﬁdence intervals (adjusted for age and sex) are presented. n ¼ 115 (pre-fortiﬁcation) and 475 (post-fortiﬁcation), To assess if these differences in synthetic
folate (folic acid) intake levels could be attributed to mandatory fortiﬁcation, patterns of dietary intakes were compared between the pre- and post-fortiﬁcation cohorts, using
standard daily serves data for a range of food groups that may inﬂuence folate intake. The only signiﬁcant difference detected in dietary intakes was a relative reduction in the
reported consumption of brassica vegetables in the post-fortiﬁcation subjects (Table 1).
Table 1
Estimated reported dietary intakes from food frequency questionnaires.
Food Group Pre-fortiﬁcation Post-fortiﬁcation p-value
Mean 95% CI Mean 95% CI
Grains total servesa 4.55 4.03e5.06 4.66 4.44e4.88 0.7
Bread productsb 2.57 2.17e2.96 2.70 2.52e2.89 0.6
Breakfast cerealsc 1.35 1.06e1.65 1.45 1.32e1.58 0.6
Pastad 0.22 0.17e0.27 0.17 0.15e0.19 0.06
Riced 0.26 0.19e0.34 0.28 0.25e0.31 0.6
Noodlesd 0.13 0.07e0.11 0.07 0.04e0.09 0.06
Vegetables total servese 5.26 4.74e5.78 5.56 5.34e5.78 0.3
Brassica vegetablesf 0.74 0.61e0.85 0.54 0.49e0.59 0.003
Fruit total servesg 3.11 2.68e3.53 3.09 2.90e3.27 0.9
Meats & protein alternatives total servesh 3.12 2.78e3.46 3.14 2.99e3.29 0.9
Red Meati 1.20 1.03e1.37 1.32 1.25e1.40 0.2
Poultryj 0.38 0.31e0.44 0.34 0.32e0.37 0.3
Seafoodk 0.29 0.23e0.35 0.33 0.30e0.35 0.2
Legumes/beans/toful 0.15 0.10e0.20 0.14 0.12e0.16 0.7
Eggsm 0.27 0.21e0.33 0.31 0.28e0.33 0.2
Nutsn 0.35 0.21e0.49 0.31 0.25e0.37 0.9
Processed meatso 0.32 0.23e0.40 0.38 0.35e0.43 0.2
Dairyp 1.73 1.50e1.96 1.65 1.55e1.75 0.5
Alcoholq 1.22 0.93e1.52 1.04 0.91e1.16 0.3
Smoking history % (current/previously/never) 50/47/3 42/34/24 0.01
Outcomes were considered to be statistically signiﬁcant at p  0.05 (Bold).
a Includes bread, breakfast cereals, pasta, rice, noodles & other grains. ~500 kJ per standard serve.
b Includes bread (1 slice, ½medium bread roll or 40 g per serve), crisp-bread (3 or 45 g per serve), english mufﬁns (1 small or 35 g per serve), crumpets (1 or 60 g per serve),
ﬂatbread & tortillas (½ each or 40 g per serve).
c Breakfast cereals (2/3 cup, 30 g or 2 biscuits per serve), including porridge (1/2 cup or 120 g cooked porridge per serve).
d ½ cup cooked per serve.
e Does not include beans or legumes (included in protein alternatives), except green peas. Includes potatoes & other starchy vegetables (1/2 medium per serve)& tomatoes
(1 medium per serve). For all other vegetables ½ cup cooked or 1 cup raw per standard serve. ~100e350 kJ per serve.
f Includes broccoli, cauliﬂower, cabbage, & brussel sprouts. Reported consumption of other brassica vegetables were negligible.
g 1 medium or two small fruits, a “handful” of dried fruit, 1 cup of fruit juice, or 1 cup of diced or canned fruit, ~350 kJ per standard serve.
h Includes red meat, poultry, ﬁsh, seafood, legumes, beans, tofu, eggs nuts & processed meats. ~500e600 kJ per standard serve.
i 65 g cooked weight per serve.
j 80 g cooked weight per serve.
k 1 ﬁllet, 100 g cooked ﬁsh, 115 g raw ﬁsh, 1 small can of ﬁsh or ½ cup other seafood (crab, prawn, lobster oyster or salted ﬁsh) per serve.
l Includes legumes & beans (1 cup cooked per serve) & tofu (~170 g per serve).
m 2 large eggs per serve.
n Includes nuts, seeds, & nut/seed pastes (30 g per serve).
o Includes bacon & deli meats.
p Includes milk&milk alternatives (1 cup fresh, UHT, long-life or reconstituted from powder or½ cup evaporated per serve), cheese (40 g or 2 slices per serve)& yoghurt (3/
4 cup or 200 g).
q ~10 g alcohol per standard drink. Least-squares means and conﬁdence intervals (adjusted for age and sex) are presented. n ¼ 115 (pre-fortiﬁcation) and 475 (post-fortiﬁcation).
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Fig. 3. A) Relationship between age and Hcy in the pre-fortiﬁcation cohort (r2 ¼ 0.330, p ¼ 0.0003). B) Relationship between age and Hcy in the post-fortiﬁcation cohort (r2 ¼ 0.010,
p ¼ 0.3). p-interaction (age x cohort) ¼ 0.05. Unadjusted data are presented, however, additional adjustment for sex, smoking history, alcohol intake and vitamin B12 levels did not
signiﬁcantly alter these results. n ¼ 115 (pre-fortiﬁcation) and 475 (post-fortiﬁcation).
E.L. Beckett et al. / Journal of Nutrition & Intermediary Metabolism 8 (2017) 14e2018fortiﬁcation and not to other dietary changes over time. Addition-
ally, the results presented here indicate that mandatory fortiﬁca-
tion may mitigate the effect of age on Hcy levels. This is important,
as the elderly are at increased risk of morbidities associated with
hyperhomocysteinemia.
These ﬁndings are largely consistent with those reported for
different regimens of mandatory fortiﬁcation in other countries
[55,56], however, magnitude of effect size varies. The results re-
ported here reﬂect changes in plasma folate and Hcy levels previ-
ously identiﬁed in the Framingham Offspring Study cohort
following the introduction of mandatory folic acid fortiﬁcation in
the USA [55]. However, in the Framingham Offspring Study, forti-
ﬁcation appeared to have a larger impact on folate status, with a
12 nmol/L increase in the mean plasma folate levels post-
fortiﬁcation, compared to a 4.1 nmol/L increase in serum folate in
the present study.
The discrepancy in ﬁndings may be explained by differences in:
the period of time elapsed between the commencement of fortiﬁ-
cation and sample collection; sample collection duration; patterns
of use of voluntary fortiﬁcation prior to mandatory fortiﬁcation;
country-speciﬁc phase-in policies; dietary habits; assay methods;
and assessment of a broader age cohort in the former study relative
to the present study. In the USA all enriched ﬂour, rice, pasta,
cornmeal, and other grain products must contain 140 mg of folic
acid per 100 g [55], whereas the Australian policy is limited to
bread-making wheat ﬂours only at a level of 120e135 mg of folic
acid per 100 g [1].
However, it is interesting that the relative magnitude of change
in folate status was not reﬂected in themagnitude of change seen in
Hcy levels. A reduction in mean Hcy levels of approximately
0.7 mmol/L was detected in the Framingham Offspring Study [55],
compared to 3.9 mmol/L in the present cohort. As stated above, this
may reﬂect different assay methods, or it may demonstrate an
increased beneﬁt in the elderly cohort. However, a similar magni-
tude of Hcy reduction (5.5 mmol/L) was identiﬁed in women of
reproductive age when mandatory fortiﬁcation was introduced in
Iran (150 mg/100 g ﬂour) [56]. Varying time-frames of the
commencement and duration of sample collection relative to the
implementation of fortiﬁcation, and different phase-in policies
between countries, may also explain these differences.
Another intervention study in an elderly cohort (50e75 years;n ¼ 143), using folate-fortiﬁed bread, reported a mean reduction in
Hcy of 1.6 mmol/L after 12 weeks [57]. This small reduction was in
spite of the participants increasing folic acid intake by almost
600 mg per day [57], considerably more than the estimated
increased intake following mandatory fortiﬁcation. This may indi-
cate that a longer period of increased consumption is more
important than a high dose in the management of Hcy levels. This
hypothesis is supported by another study of 18e80 year olds using
fortiﬁed breakfast cereals (200 mg/day) which found an incremental
decrease in mean Hcy levels over time, with a 0.6 mmol/L reduction
after 4 weeks, and a reduction of 1.1 mmol/L after 24weeks [58]. The
inﬂuence of time-frame of supplementation on Hcy levels requires
further investigation.
The results reported here also support the ﬁndings of Hickling
et al. [54] who found a reduction in Hcy levels and rates of hyper-
homocysteinemia in an Australian longitudinal cohort assessed in
1995 and in 2001. In 1995 few foods were fortiﬁed with folic acid,
and in 2001 approximately 50% of breakfast cereals available in
Australia were voluntarily fortiﬁed [54]. The serum folate values
obtained in 2001 (mean 23.1 nmol/L) were similar to those found in
the pre-fortiﬁcation cohort presented here (mean 23.9 nmol/L),
suggesting that the current pre-fortiﬁcation cohort was represen-
tative of a voluntary fortiﬁcation cohort. The combined ﬁndings of
the two studies clearly shows the incremental improvement of
folate status via voluntary and then mandatory fortiﬁcation in
Australia. Notably, the Hcy levels in the 2001 cohort (2.4 mmol/L)
were considerably lower than in the present pre-fortiﬁcation
cohort, although this is likely due to the inclusion of younger par-
ticipants (27e77 years) in the earlier cohort [54].
Analysis of the food frequency and supplement questionnaire
data demonstrated that the observed increase in serum and red cell
folate levels was not related to changes in the consumption of foods
not subject to mandatory fortiﬁcation, or supplement usage. In fact,
in the present study, blood folate levels were higher post-
fortiﬁcation, despite reduced reported consumption of brassica
vegetables, which are high in folate, and decreased reported usage
of folate containing supplements. This suggests mandatory fortiﬁ-
cation is the principal factor associated with the increased blood
folate levels and associated decrease in circulating Hcy. This is
further demonstrated by the change in estimated intake of syn-
thetic, and not natural forms of folate. While there are notable
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tionnaires, including potential over reporting of healthful foods and
under-reporting of discretionary foods they are useful for com-
parisons of habitual intakes, and useful for comparisons between
groups.
Although the use of two independent cohorts, rather than a
longitudinal follow-up of the same subjects may be seen as a lim-
itation of this study, it reduces the inﬂuence of an aging cohort on
the outcome. Hcy levels are known to increase with age, and di-
etary habits may also vary with age and deterioration of taste
sensation. Assessing two independent cohorts, sourced from the
same geographical area, allows us to speciﬁcally assess the inﬂu-
ence of mandatory folate fortiﬁcation in the elderly demographic
with minimal impact from these potentially confounding factors,
and reduces the potential impact of participant loss to follow-up.
Adjustments were applied where variables were known to inﬂu-
ence outcomes of interest, or means varied between groups.
However, the potential for undocumented differences in the two
convenience samples used cannot be discounted.
Adjustment of the analyses here for factors known to inﬂuence
Hcy levels (vitamin B12 levels, alcohol consumption, smoking, age,
and sex) strengthens the results presented here. However, it is a
limitation of the study design that other factors known to inﬂuence
Hcy, such as physical activity [6], were not able to be controlled for.
Themitigation of the relationships between age and plasma Hcy
in the post-fortiﬁcation cohort generates optimism that reduced
disease risk in the elderly, a particularly at-risk cohort, may be
achievable with continued fortiﬁcation. It is possible that
population-wide fortiﬁcation over an extended time-frame may be
more successful in reducing symptoms and risk of cardiovascular
and neurodegenerative diseases than previous intervention
studies. Additional studies are needed to determine if the lowering
of Hcy levels in post-fortiﬁcation cohorts results in a reduction of
risk of cardiovascular and neurodegenerative diseases. Although
the post-fortiﬁcation group was older on average, this reﬂects the
higher maximum age, as such, the abrogation of the relationship
between age and homocysteine in this larger study group is even
more striking.
While the introduction of a mandatory folate fortiﬁcation pro-
gram that impacts the broader population to beneﬁt a small per-
centage of the population may be seen as controversial, the results
presented here demonstrate a potential beneﬁt of folate fortiﬁca-
tion in the elderly. Decreasedmean plasma Hcy and decreased rates
of hyperhomocysteinemia across all age groups, may translate into
a decreased disease burden in the Australian population in future
generations, particularly if coupled with additional risk reduction
strategies. The results presented here constitute important infor-
mation to be considered by policy makers in jurisdictions that are
still considering the potential risks and beneﬁts of fortiﬁcation.
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